This site will be switched off, between 1 July and 10 July.
Content for professionals is now on GOV.UK and general screening content for the public is on NHS Choices.
You are here: About Us > About Us

About Us


The NHS Screening Programmes have become part of Public Health England (PHE), an executive agency of the Department of Health. PHE also supports the UK National Screening Committee.

Public Health England has been established to protect and improve the nation’s health and wellbeing and to reduce inequalities. It will lead on the development of a 21st-century health and wellbeing service, supporting local authorities and the NHS to deliver the greatest possible improvements in public health. It came into being in April 2013. For all corporate information please see


1. Aims of the programme

The NHS Infectious Diseases in Pregnancy Screening (IDPS) Programme advocates that all pregnant women are offered screening for hepatitis B, HIV, syphilis and susceptibility to rubella infection.

The programme aims to ensure that women with hepatitis B, HIV and syphilis are identified early in pregnancy to:

  • facilitate appropriate assessment and management for their health
  • reduce the risk of mother-to-child transmission of these conditions. 

The programme also currently screens to identify women who are susceptible to rubella, for whom postnatal MMR vaccination could protect future pregnancies.


2. Programme structure and governance

The National Programme Manager is Sharon Webb who works closely with the Clinical Advisor for the programme Professor Catherine Peckham.

The Programme is accountable to the UK NSC's Fetal, Maternal and Child Health (FMCH) Group and the UK NSC Director of Programmes. In line with Public Health England governance processes, the UK NSC is currently reviewing the screening programme advisory framework.

Support for specific work streams is aligned from other members in the UK National Screening National Programmes and Quality Assurance Teams, specifically:

  • Quality Assurrance- Elizabeth Dormandy
  • Communications- Nick Waddell-Johnstone   
  • Education & Training- Lindsay Kimm  

The Programme works collaboratively with other PHE organisations and external stakeholders on specific projects:

  • The epidemiology team at The Institute of Child Health, UCLH London
  • The PHE Immunisation Team
  • The PHE National Antenatal Infections Screening Monitoring (NAISM) Team

3. Policies

The UK NSC currently recommends systematic population antenatal  screening for:

The UK NSC also has policies covering screening for other infectious diseases in the antenatal period, for which screening is not currently recommended. Click on one of the following links to see the UK NSC policy position on:

The policy documents will be available to be downloaded from this page in the near future.


4. Standards

The NHS non-cancer screening programmes are working to formulate a standardised process for the production of consistent and measurable standards for screening programmes. The Infectious Diseases in Pregnancy Screening Programme is currently reviewing the 2010 Programme Standards.

Whilst the new review process is being agreed, the current standards continue to apply and are used in conjunction with the revised IDPS Service Specification (2014/15) to inform local service provision. Notification will be given when revised standards are ready for consultation, publication and implementation.

page image